9 days ago
Bengaluru: When batters are scoring at 11.46 runs an over, even quality bowling attacks can be made to look ordinary. India's T20I series against the West Indies has exposed the vulnerability of the hosts' pace unit, with flat pitches, dew and short boundaries proving a punishing combination for bowlers.
West Indies' stunning 250-run chase in Ranchi, completed with nine **** to spare, prompted a stern **** sment from India head coach Gautam Gambhir.
"These bowlers are our bowlers, not someone else's bowlers. Their careers are at stake," he had said, underlining the scrutiny facing the attack.
With the exception of Indore, where India successfully defended 223, the bowlers struggled to contain a fearless West Indies batting line-up. While the absence of Jasprit **** rah and, to an extent, Hardik Pandya has been felt, the bigger concern for the team management is the inconsistency shown by Arshdeep Singh, Mayank Yadav and Prince Yadav.
The two young quicks, Mayank and Prince, have alternated between brilliance and waywardness during the series, highlighting the challenges of adjusting to different match situations. The fourth T20I in Hyderabad offered a clear example. India conceded 18 extras, including 13 wides. Arshdeep accounted for six, while Mayank and Prince leaked two and one, respectively. Their attempts to execute wide yorkers and fuller deliveries repeatedly missed the mark, allowing the West Indies batters to maintain the pressure.
India's lack of proven T20 pace-bowling depth has consequently become a talking point. That has put renewed focus on the return of Bhuvneshwar **** ar, whose recall after nearly four years away from the national side could prove timely.
The experienced swing bowler has enjoyed a productive run in the IPL, taking 45 wickets across the last two seasons. More importantly, his success has been built on control and execution rather than sheer pace, qualities that India's younger quicks have often lacked in this series.
Conditions, however, have offered little respite to bowlers. High-scoring surfaces and heavy dew have meant that even small lapses have come at a significant cost.
As India prepare for a demanding tour of New Zealand, they know the challenges ahead will be very different. The pitches may offer more **** istance, but the key question remains whether the bowling group can quickly adapt and improve its consistency.
On the eve of the rain-affected series finale in Bengaluru, fast-bowling coach Morne Morkel urged observers to consider the physical and mental demands placed on modern cricketers.
"We sometimes forget that mental fatigue plays a big part. We have to manage that and be smart with it. Some of the players went for the Asian Games and then straight into a full series against the West Indies. These guys are also human," Morkel said.
"Execution and skills become better when you've recovered, slept well and mentally refreshed. That's a challenge. We're going to N
West Indies' stunning 250-run chase in Ranchi, completed with nine **** to spare, prompted a stern **** sment from India head coach Gautam Gambhir.
"These bowlers are our bowlers, not someone else's bowlers. Their careers are at stake," he had said, underlining the scrutiny facing the attack.
With the exception of Indore, where India successfully defended 223, the bowlers struggled to contain a fearless West Indies batting line-up. While the absence of Jasprit **** rah and, to an extent, Hardik Pandya has been felt, the bigger concern for the team management is the inconsistency shown by Arshdeep Singh, Mayank Yadav and Prince Yadav.
The two young quicks, Mayank and Prince, have alternated between brilliance and waywardness during the series, highlighting the challenges of adjusting to different match situations. The fourth T20I in Hyderabad offered a clear example. India conceded 18 extras, including 13 wides. Arshdeep accounted for six, while Mayank and Prince leaked two and one, respectively. Their attempts to execute wide yorkers and fuller deliveries repeatedly missed the mark, allowing the West Indies batters to maintain the pressure.
India's lack of proven T20 pace-bowling depth has consequently become a talking point. That has put renewed focus on the return of Bhuvneshwar **** ar, whose recall after nearly four years away from the national side could prove timely.
The experienced swing bowler has enjoyed a productive run in the IPL, taking 45 wickets across the last two seasons. More importantly, his success has been built on control and execution rather than sheer pace, qualities that India's younger quicks have often lacked in this series.
Conditions, however, have offered little respite to bowlers. High-scoring surfaces and heavy dew have meant that even small lapses have come at a significant cost.
As India prepare for a demanding tour of New Zealand, they know the challenges ahead will be very different. The pitches may offer more **** istance, but the key question remains whether the bowling group can quickly adapt and improve its consistency.
On the eve of the rain-affected series finale in Bengaluru, fast-bowling coach Morne Morkel urged observers to consider the physical and mental demands placed on modern cricketers.
"We sometimes forget that mental fatigue plays a big part. We have to manage that and be smart with it. Some of the players went for the Asian Games and then straight into a full series against the West Indies. These guys are also human," Morkel said.
"Execution and skills become better when you've recovered, slept well and mentally refreshed. That's a challenge. We're going to N
20 days ago
Christa Pike is feeling "angry and confused" after waking up in the hospital in the wake of a failed execution attempt that left her with severe physical health challenges that put her on a "long road to recovery," her attorneys said on Wednesday.
Pike had been unconscious and in critical condition in the days after two doses of pentobarbital failed to end her life on Sept. 30, they said.
"On Monday night, it was our understanding that Christa was brain-dead and that life support would be removed the next day," Randy Spivey, a member of her legal team, said during a press conference Wednesday afternoon. "But on Tuesday, to the shock of everyone … Christa woke up and began talking."
Spivey said the effects of the pentobarbital have caused her to develop a blood clot, pneumonia and left her arms and hands "tremendously swollen," to the point where she's not currently able to use them. He added that Pike is still dealing with significant "cognitive confusion," but is "very aware" that the state had tried and failed to end her life.
The press conference came shortly after a hearing in which a judge granted Pike's attorneys' request to order the state to preserve all evidence connected to the execution, including medical equipment, communications related to the decision to call off the procedure or related to her emergency care and "anything that was in the actual room." The judge also ordered that any "barriers" that may prevent Pike from communicating with her attorneys while she's in the hospital be removed.
#attorneys #execution
Pike had been unconscious and in critical condition in the days after two doses of pentobarbital failed to end her life on Sept. 30, they said.
"On Monday night, it was our understanding that Christa was brain-dead and that life support would be removed the next day," Randy Spivey, a member of her legal team, said during a press conference Wednesday afternoon. "But on Tuesday, to the shock of everyone … Christa woke up and began talking."
Spivey said the effects of the pentobarbital have caused her to develop a blood clot, pneumonia and left her arms and hands "tremendously swollen," to the point where she's not currently able to use them. He added that Pike is still dealing with significant "cognitive confusion," but is "very aware" that the state had tried and failed to end her life.
The press conference came shortly after a hearing in which a judge granted Pike's attorneys' request to order the state to preserve all evidence connected to the execution, including medical equipment, communications related to the decision to call off the procedure or related to her emergency care and "anything that was in the actual room." The judge also ordered that any "barriers" that may prevent Pike from communicating with her attorneys while she's in the hospital be removed.
#attorneys #execution
21 days ago
What was the outcome of the 1947 Supreme Court case on second executions?
What legal argument do experts use to differentiate Pike's case from 1947?
Why do experts argue a second execution attempt would be unconstitutional?
Full Summary
With the astonishing news that Christa Pike is conscious, talking and making a "medically unprecedented" recovery following her botched execution, Tennessee is now facing a critical question: Will the state try to kill her again?
#second #execution #supreme #court
What legal argument do experts use to differentiate Pike's case from 1947?
Why do experts argue a second execution attempt would be unconstitutional?
Full Summary
With the astonishing news that Christa Pike is conscious, talking and making a "medically unprecedented" recovery following her botched execution, Tennessee is now facing a critical question: Will the state try to kill her again?
#second #execution #supreme #court
21 days ago
It will be the first U.S. military execution in more than 60 years.
Nidal Hasan, who was sentenced to death for the 2009 mass shooting at Fort Hood, Texas, will be executed by firing squad on Dec. 3, according to a memo from the acting Army secretary.
The execution, the first carried out by the U.S. military in more than 60 years, is scheduled for 1 p.m. CT, according to the memo issued Tuesday by acting Army Secretary Adam Telle.
The Pentagon announced Monday that Hasan would be executed by firing squad after President Donald Trump approved the decision Friday.
Under the military’s execution process for prisoners on death row, the Army secretary initiates the proceedings, which then require approval from the defense secretary and eventually the president.
#military
Nidal Hasan, who was sentenced to death for the 2009 mass shooting at Fort Hood, Texas, will be executed by firing squad on Dec. 3, according to a memo from the acting Army secretary.
The execution, the first carried out by the U.S. military in more than 60 years, is scheduled for 1 p.m. CT, according to the memo issued Tuesday by acting Army Secretary Adam Telle.
The Pentagon announced Monday that Hasan would be executed by firing squad after President Donald Trump approved the decision Friday.
Under the military’s execution process for prisoners on death row, the Army secretary initiates the proceedings, which then require approval from the defense secretary and eventually the president.
#military
22 days ago
Four major corporate splits are upcoming, with MSGS separating the Knicks and Rangers into two distinct public companies by October 2026.
Keurig Dr Pepper's coffee spinoff carries significant execution risk as Russ Torres becomes its third CEO candidate ahead of the early 2027 split.
Textron leans toward selling its $3 billion Industrial segment rather than spinning it off, meaning shareholders would receive no second stock.
Building a portfolio and living off one are two completely different skills, and almost ******* ody teaches the second. This problem is what The Definitive Guide to Retirement Income helps, and it is free today. Read more here. (Sponsor)
Corteva (NYSE:CTVA) has split into two companies, and we walked through what its shareholders own now. Four more large separations are coming. Each has its own timeline, and each leaves shareholders holding something different. They are listed below by expected timing, soonest first.
#split #second #different
Keurig Dr Pepper's coffee spinoff carries significant execution risk as Russ Torres becomes its third CEO candidate ahead of the early 2027 split.
Textron leans toward selling its $3 billion Industrial segment rather than spinning it off, meaning shareholders would receive no second stock.
Building a portfolio and living off one are two completely different skills, and almost ******* ody teaches the second. This problem is what The Definitive Guide to Retirement Income helps, and it is free today. Read more here. (Sponsor)
Corteva (NYSE:CTVA) has split into two companies, and we walked through what its shareholders own now. Four more large separations are coming. Each has its own timeline, and each leaves shareholders holding something different. They are listed below by expected timing, soonest first.
#split #second #different
22 days ago
Nidal Malik Hasan, a former Army major who killed 13 people in a 2009 mass shooting at Fort Hood, Texas, will be executed by firing squad, the Pentagon announced Monday.
"Secretary of War Pete Hegseth has recommended — and President Donald J. Trump has approved — death by U.S. Army firing squad for convicted terrorist Nidal Malik Hasan, the jihadist who opened fire on unarmed American soldiers at Fort Hood in 2009," chief Pentagon spokesman Sean Parnell wrote on X.
He added, "The Secretary of the Army will set the time and place of the execution. Judgement day for Hasan has finally come."
The U.S. military has not carried out an execution since 1961 and has not used a firing squad to execute a service member since World War II.
The announcement of Trump's approval came days after a failed attempt to execute Christa Pike by lethal injection. The failed execution prompted Tennessee's governor to halt further executions this year and order a third-party review.
#firing #squad #nidal #fort
"Secretary of War Pete Hegseth has recommended — and President Donald J. Trump has approved — death by U.S. Army firing squad for convicted terrorist Nidal Malik Hasan, the jihadist who opened fire on unarmed American soldiers at Fort Hood in 2009," chief Pentagon spokesman Sean Parnell wrote on X.
He added, "The Secretary of the Army will set the time and place of the execution. Judgement day for Hasan has finally come."
The U.S. military has not carried out an execution since 1961 and has not used a firing squad to execute a service member since World War II.
The announcement of Trump's approval came days after a failed attempt to execute Christa Pike by lethal injection. The failed execution prompted Tennessee's governor to halt further executions this year and order a third-party review.
#firing #squad #nidal #fort
22 days ago
Why did John Thune say there's no path forward for the bill?
What safety concerns did Roger Wicker raise about the bill?
Why was Christa Pike’s execution halted in Tennessee?
Full Summary
Senate Majority Leader John Thune said in an Oct. 5 interview that "there’s no clear path forward" for legislation that would make daylight saving time permanent.
#john #path #bill #Roger
What safety concerns did Roger Wicker raise about the bill?
Why was Christa Pike’s execution halted in Tennessee?
Full Summary
Senate Majority Leader John Thune said in an Oct. 5 interview that "there’s no clear path forward" for legislation that would make daylight saving time permanent.
#john #path #bill #Roger
22 days ago
Nidal Malik Hasan, a former Army officer and psychiatrist who killed 13 people and injured 32 others during a mass shooting at Fort Hood, Texas, in 2009, will be executed by a U.S. Army firing squad, the Pentagon announced Monday.
"Secretary of War Pete Hegseth has recommended — and President Donald J. Trump has approved — death by U.S. Army firing squad for convicted terrorist Nidal Malik Hasan, the jihadist who opened fire on unarmed American soldiers at Fort Hood in 2009," Chief Pentagon Spokesman Sean Parnell announced. "He killed 13 people and wounded 32 others while shouting 'Allahu Akbar' during the attack.
"The Secretary of the Army will set the time and place of the execution," he continued. "Judgement day for Hasan has finally come."
If Hasan's execution is indeed carried out by a firing squad, it would mark the first such case for the service since Jan. 31, 1945, when Pvt. Eddie D. Slovik was executed by a U.S. Army firing squad in France for desertion during World War II.
The last death sentence carried out by the U.S. military was in 1961, when Army Pvt. John Bennett was executed by hanging at the gallows in Fort Leavenworth, Kansas, after he was convicted of raping and attempting to kill a young girl.
#fort #firing #malik
"Secretary of War Pete Hegseth has recommended — and President Donald J. Trump has approved — death by U.S. Army firing squad for convicted terrorist Nidal Malik Hasan, the jihadist who opened fire on unarmed American soldiers at Fort Hood in 2009," Chief Pentagon Spokesman Sean Parnell announced. "He killed 13 people and wounded 32 others while shouting 'Allahu Akbar' during the attack.
"The Secretary of the Army will set the time and place of the execution," he continued. "Judgement day for Hasan has finally come."
If Hasan's execution is indeed carried out by a firing squad, it would mark the first such case for the service since Jan. 31, 1945, when Pvt. Eddie D. Slovik was executed by a U.S. Army firing squad in France for desertion during World War II.
The last death sentence carried out by the U.S. military was in 1961, when Army Pvt. John Bennett was executed by hanging at the gallows in Fort Leavenworth, Kansas, after he was convicted of raping and attempting to kill a young girl.
#fort #firing #malik
24 days ago
PUBLISHED
OCT 03, 2026 AT 07:38 PM EDT
Tennessee officials are still investigating why death row inmate Christa Pike survived an execution attempt after receiving two doses of pentobarbital, a drug intended to render a person unconscious and ultimately cause death.
While the immediate focus has been on what went wrong inside the execution chamber, experts say Pike's case has also renewed scrutiny of a problem that has been building for more than a decade: how states obtain lethal injection drugs after pharmaceutical companies moved aggressively to keep their products from being used in executions. Despite those efforts, pentobarbital remains the primary execution drug used by many death-penalty states, making questions about sourcing, testing and oversight especially significant.
The issue has reshaped how many states carry out executions, forcing them to change drug protocols, seek alternative suppliers and adopt increasingly secretive procurement practices.
#pentobarbital #executions #published #tennessee
OCT 03, 2026 AT 07:38 PM EDT
Tennessee officials are still investigating why death row inmate Christa Pike survived an execution attempt after receiving two doses of pentobarbital, a drug intended to render a person unconscious and ultimately cause death.
While the immediate focus has been on what went wrong inside the execution chamber, experts say Pike's case has also renewed scrutiny of a problem that has been building for more than a decade: how states obtain lethal injection drugs after pharmaceutical companies moved aggressively to keep their products from being used in executions. Despite those efforts, pentobarbital remains the primary execution drug used by many death-penalty states, making questions about sourcing, testing and oversight especially significant.
The issue has reshaped how many states carry out executions, forcing them to change drug protocols, seek alternative suppliers and adopt increasingly secretive procurement practices.
#pentobarbital #executions #published #tennessee
25 days ago
What type of jet is missing off Nantucket?
Where was the missing jet traveling from and to?
What was the outcome of Christa Pike's botched execution?
Full Summary
The U.S. Coast Guard is searching off the coast of Nantucket for a missing jet carrying six people after it went missing the morning of Oct. 3.
#full #guard #type #outcome
Where was the missing jet traveling from and to?
What was the outcome of Christa Pike's botched execution?
Full Summary
The U.S. Coast Guard is searching off the coast of Nantucket for a missing jet carrying six people after it went missing the morning of Oct. 3.
#full #guard #type #outcome
25 days ago
The failed execution of Christa Pike in Tennessee on Wednesday has added new fuel to the longstanding debate over the death penalty in the United States. It has also drawn new scrutiny to the question of whether lethal injection, the nation's primary method of execution for the past 40 years, is truly a "more humane" alternative to other ways of putting someone to death.
Pike was given a death sentence in 1996 after being convicted of killing her classmate, Colleen Slemmer, in an attack she carried out with her then boyfriend. After 30 years on death row, and a last-minute legal battle that temporarily delayed her execution, Pike was scheduled to be put to death on Wednesday night.
However, the two doses of pentobarbital she was given proved not to be fatal. According to witnesses, Pike remained alive and snored loudly for 40 minutes after the drugs were administered. Eventually, the execution was called off and she was taken to the hospital for treatment.
Pike's attorney Randy Spivey reported Thursday afternoon that she was in critical condition and receiving "life-saving care." She was unconscious and placed on a ventilator in the hospital, according to a filing by her legal team on Friday.
Spivey admonished the state for going forward with lethal injection despite his warnings ahead of time that a blood-clotting disorder called thrombocytosis "would cause her to suffer an agonizing death." Pike's attorneys had asked the courts to permit her to die by hanging, but the request was denied.
#pike #years #given
Pike was given a death sentence in 1996 after being convicted of killing her classmate, Colleen Slemmer, in an attack she carried out with her then boyfriend. After 30 years on death row, and a last-minute legal battle that temporarily delayed her execution, Pike was scheduled to be put to death on Wednesday night.
However, the two doses of pentobarbital she was given proved not to be fatal. According to witnesses, Pike remained alive and snored loudly for 40 minutes after the drugs were administered. Eventually, the execution was called off and she was taken to the hospital for treatment.
Pike's attorney Randy Spivey reported Thursday afternoon that she was in critical condition and receiving "life-saving care." She was unconscious and placed on a ventilator in the hospital, according to a filing by her legal team on Friday.
Spivey admonished the state for going forward with lethal injection despite his warnings ahead of time that a blood-clotting disorder called thrombocytosis "would cause her to suffer an agonizing death." Pike's attorneys had asked the courts to permit her to die by hanging, but the request was denied.
#pike #years #given
25 days ago
Correction: An earlier version of this story mistakenly said the emergency court hearing request was granted by a judge.
An Oct. 2 emergency court filing seeks to preserve all evidence related to Tennessee's failed execution of Christa Pike, arguing the state botched the lethal injection procedure.
A judge was considering the request shortly after it was filed. While an unsigned document for the hearing was filed in the court system, no date or time was immediately listed.
Pike was set to be executed by the Tennessee Department of Correction on Sept. 30, but survived two doses of pentobarbital. The document, filed in Davidson County Chancery Court on Oct. 2, revealed more details about Pike's condition. It said she is intubated, on a ventilator and unconscious, and that both her arms were swollen, burned and blistered. As of the night of Oct. 1, Pike was still in critical condition at a Nashville-area hospital, the motion said.
"Hospital staff are working to save Ms. Pike's life and to clear the pentobarbital from her system," the Oct. 2 motion stated.
#pike #correction #hospital #hearing
An Oct. 2 emergency court filing seeks to preserve all evidence related to Tennessee's failed execution of Christa Pike, arguing the state botched the lethal injection procedure.
A judge was considering the request shortly after it was filed. While an unsigned document for the hearing was filed in the court system, no date or time was immediately listed.
Pike was set to be executed by the Tennessee Department of Correction on Sept. 30, but survived two doses of pentobarbital. The document, filed in Davidson County Chancery Court on Oct. 2, revealed more details about Pike's condition. It said she is intubated, on a ventilator and unconscious, and that both her arms were swollen, burned and blistered. As of the night of Oct. 1, Pike was still in critical condition at a Nashville-area hospital, the motion said.
"Hospital staff are working to save Ms. Pike's life and to clear the pentobarbital from her system," the Oct. 2 motion stated.
#pike #correction #hospital #hearing
26 days ago
The mother of the woman killed by Christa Pike said she was left without justice after Tennessee's failed attempt to carry out the execution, criticizing the state's handling of a procedure that left the death row prisoner hospitalized in critical condition.
"I didn't get justice for my daughter," May Martinez, whose daughter Colleen Slemmer was killed in 1995, told the ******* ociated Press on Thursday.
Martinez traveled to Nashville to witness the execution Wednesday. Instead, she watched as officials administered two doses of the state's execution drug pentobarbital without killing Pike.
"I watched the whole thing. She was awake," she said. "She was moving her head, moving her feet. She was trying to sit up. Didn't work the first time they gave her a shot. It didn't work the second time, so she's in the hospital and alive."
The inmate is receiving life-saving medical care, according to her legal team, who have asked Tennessee Gov. Bill Lee to commute her sentence.
#execution #left
"I didn't get justice for my daughter," May Martinez, whose daughter Colleen Slemmer was killed in 1995, told the ******* ociated Press on Thursday.
Martinez traveled to Nashville to witness the execution Wednesday. Instead, she watched as officials administered two doses of the state's execution drug pentobarbital without killing Pike.
"I watched the whole thing. She was awake," she said. "She was moving her head, moving her feet. She was trying to sit up. Didn't work the first time they gave her a shot. It didn't work the second time, so she's in the hospital and alive."
The inmate is receiving life-saving medical care, according to her legal team, who have asked Tennessee Gov. Bill Lee to commute her sentence.
#execution #left
27 days ago
The lethal drug administered in Tennessee's failed attempt to execute Christa Pike has been used in multiple states that carry out the death penalty and by the U.S. government after President Donald Trump resumed federal executions during his first term.
Pike, 50, remained alive after two doses of pentobarbital were administered Wednesday, according to her attorneys and media witnesses. One of her lawyers said Thursday that she was being treated at a hospital.
Tennessee officials haven't explained yet what went wrong during the execution.
Republican Gov. Bill Lee ordered a third-party review to determine what happened and said another scheduled execution in Tennessee will not take place this year.
Pentobarbital is a barbiturate, a class of drugs that depresses the central nervous system.
#pike #administered #execution #wednesday
Pike, 50, remained alive after two doses of pentobarbital were administered Wednesday, according to her attorneys and media witnesses. One of her lawyers said Thursday that she was being treated at a hospital.
Tennessee officials haven't explained yet what went wrong during the execution.
Republican Gov. Bill Lee ordered a third-party review to determine what happened and said another scheduled execution in Tennessee will not take place this year.
Pentobarbital is a barbiturate, a class of drugs that depresses the central nervous system.
#pike #administered #execution #wednesday
27 days ago
Tennessee's only female death row inmate has been taken to the hospital after surviving two doses of lethal injection drugs, her lawyers said.
Christa Pike, 50, was alive and snoring loudly after being given two doses of pentobarbital, her attorneys said.
Pike had been scheduled for execution 10 a.m. Wednesday for a killing she committed at age 18. She would have been the first woman executed in Tennessee in more than 200 years.
An appeals court stopped the lethal injection just an hour before it was to start. The U.S. Supreme Court overturned that stay shortly after.
Media witnesses said officials raised the curtains to the execution chamber at 7:27 p.m., showing Pike strapped to a gurney. "I'm going to leave this world the way I spent most of my life, and that is in love," she said in her "last" words.
#doses #christa
Christa Pike, 50, was alive and snoring loudly after being given two doses of pentobarbital, her attorneys said.
Pike had been scheduled for execution 10 a.m. Wednesday for a killing she committed at age 18. She would have been the first woman executed in Tennessee in more than 200 years.
An appeals court stopped the lethal injection just an hour before it was to start. The U.S. Supreme Court overturned that stay shortly after.
Media witnesses said officials raised the curtains to the execution chamber at 7:27 p.m., showing Pike strapped to a gurney. "I'm going to leave this world the way I spent most of my life, and that is in love," she said in her "last" words.
#doses #christa
27 days ago
NASHVILLE, Tenn. (AP) — The Tennessee governor ordered an outside investigation and halted executions late Wednesday, hours after an inmate survived a lethal injection attempt.
Tennessee officials were unable to put Christa Gail Pike to death for a 1995 murder after administering two doses of a lethal drug. A death penalty expert said it was an unprecedented failure.
Gov. Bill Lee said in a statement that he has ordered "a comprehensive, third-party review to determine exactly what occurred" and that scheduled executions will not be carried out this year.
"Carrying out a lawfully imposed sentence is among the State's most serious responsibilities, and the people of Tennessee expect it to be done in a manner that is not only legal and constitutional, but is effective," he said.
Tennessee only has one other execution scheduled this year.
#tennessee #death #year
Tennessee officials were unable to put Christa Gail Pike to death for a 1995 murder after administering two doses of a lethal drug. A death penalty expert said it was an unprecedented failure.
Gov. Bill Lee said in a statement that he has ordered "a comprehensive, third-party review to determine exactly what occurred" and that scheduled executions will not be carried out this year.
"Carrying out a lawfully imposed sentence is among the State's most serious responsibilities, and the people of Tennessee expect it to be done in a manner that is not only legal and constitutional, but is effective," he said.
Tennessee only has one other execution scheduled this year.
#tennessee #death #year
28 days ago
How many women have been executed in the U.S. in the last 50 years?
What legal arguments did Pike's attorneys use for clemency?
What specific allegations did the report find credible against Dale Caldwell?
Full Summary
Christa Pike, Tennessee's only female death row inmate, has lost her final appeal after the U.S. Supreme Court declined to intervene in her imminent execution.
#full #court
What legal arguments did Pike's attorneys use for clemency?
What specific allegations did the report find credible against Dale Caldwell?
Full Summary
Christa Pike, Tennessee's only female death row inmate, has lost her final appeal after the U.S. Supreme Court declined to intervene in her imminent execution.
#full #court
30 days ago
Vista Gold Corp. (NYSEAMERICAN:VGZ) announced on September 21 that it had agreed to be acquired by Artemis Gold Inc. (TSXV:ARTG). Under the agreement signed September 20, shareholders would receive 0.0966 buyer common shares for each existing common share and own approximately 5% of the combined company. That ownership calculation excludes the buyer's existing 4.95% stake in Vista Gold Corp. (NYSEAMERICAN:VGZ), which it intends to cancel at completion.
For shareholders, the trade-off is a smaller interest in a larger mining business with an operating ***** et and development expertise. The central question is whether that combination can supply the capital and execution needed to bring Australia's Mt Todd gold project into production.
Artemis Gold Inc. (TSXV:ARTG) operates the Blackwater mine in British Columbia and expects its future cash generation to support Mt Todd. That offers Vista Gold a potential funding source alongside a team experienced in building and operating mines.
The financial starting point explains the appeal. Vista Gold Corp. (NYSEAMERICAN:VGZ) ended June 2026 with $49.5 million in cash and no debt. Management described that cash as sufficient for interim development objectives. Joining an operating producer could broaden the resources available for the much larger task of construction.
The acquisition requires no cash consideration or new acquisition debt. Preserving the buyer's financial capacity could leave more room for investment, although the share exchange itself does not raise construction funding.
#cash
For shareholders, the trade-off is a smaller interest in a larger mining business with an operating ***** et and development expertise. The central question is whether that combination can supply the capital and execution needed to bring Australia's Mt Todd gold project into production.
Artemis Gold Inc. (TSXV:ARTG) operates the Blackwater mine in British Columbia and expects its future cash generation to support Mt Todd. That offers Vista Gold a potential funding source alongside a team experienced in building and operating mines.
The financial starting point explains the appeal. Vista Gold Corp. (NYSEAMERICAN:VGZ) ended June 2026 with $49.5 million in cash and no debt. Management described that cash as sufficient for interim development objectives. Joining an operating producer could broaden the resources available for the much larger task of construction.
The acquisition requires no cash consideration or new acquisition debt. Preserving the buyer's financial capacity could leave more room for investment, although the share exchange itself does not raise construction funding.
#cash
1 month ago
Phillips 66 (NYSE:PSX) has been on a strong rally this year, posting gains of over 110% since the beginning of 2026. The outperformance has been driven by an unusually sharp surge in global refining margins amid the war in the Middle East, which has significantly tightened the world's refining capacity and reduced supplies of gasoline, diesel, and jet fuel.
Given Phillips 66's substantial outperformance compared to the wider market, investors may be questioning whether the stock's record-setting run has reached its peak. However, the ****** ysts over at BMO Capital see further upside ahead. On September 17, the firm raised its price target on PSX from $260 to $310, while maintaining an 'Outperform' rating on the shares. The target boost implies an upside of 13% from the current levels and even exceeds the stock's all-time high of over $274 achieved earlier this month.
BMO Capital highlighted Phillips 66's integrated business model, noting that it has gained momentum and outperformed its individual segments, supported by strong execution across the portfolio. While Refining and Renewables remain the cyclical leaders, BMO also sees a favorable medium-term growth outlook for the company's Midstream business.
BMO Capital's vote of confidence comes amid a broader optimism surrounding Phillips 66, with ****** ysts from Morgan Stanley, Raymon James, UBS, and several others also improving their respective outlooks on PSX. This suggests that Wall Street expects the ongoing refining upcycle to last longer than previously expected, particularly following the renewed escalations between Iran and the United States.
The supply disruptions now extend beyond the troubled region, as a recent wave of Ukrainian attacks on Russian refineries has further reduced global refining capacity and provided further support to margins.
#further #margins #amid
Given Phillips 66's substantial outperformance compared to the wider market, investors may be questioning whether the stock's record-setting run has reached its peak. However, the ****** ysts over at BMO Capital see further upside ahead. On September 17, the firm raised its price target on PSX from $260 to $310, while maintaining an 'Outperform' rating on the shares. The target boost implies an upside of 13% from the current levels and even exceeds the stock's all-time high of over $274 achieved earlier this month.
BMO Capital highlighted Phillips 66's integrated business model, noting that it has gained momentum and outperformed its individual segments, supported by strong execution across the portfolio. While Refining and Renewables remain the cyclical leaders, BMO also sees a favorable medium-term growth outlook for the company's Midstream business.
BMO Capital's vote of confidence comes amid a broader optimism surrounding Phillips 66, with ****** ysts from Morgan Stanley, Raymon James, UBS, and several others also improving their respective outlooks on PSX. This suggests that Wall Street expects the ongoing refining upcycle to last longer than previously expected, particularly following the renewed escalations between Iran and the United States.
The supply disruptions now extend beyond the troubled region, as a recent wave of Ukrainian attacks on Russian refineries has further reduced global refining capacity and provided further support to margins.
#further #margins #amid
1 month ago
Elon Musk has never shied away from ambitious timelines, and his most recent one connects two companies directly together. In a post on X dated September 13, Musk stated that he is "highly confident" that **** e Exploration Technologies Corp. (NASDAQ:SPCX) will transport NVIDIA Corporation (NASDAQ:NVDA) Vera Rubin NVL72 AI computers into orbit next year, repeating a plan that has already moved both companies' stock this year.
The comment strengthens **** eX's Starmind concept, which aims to establish AI data centers in orbit rather than on the ground. The first satellite, named Starmind AI1, will carry a **** e-optimized version of NVIDIA's Vera Rubin NVL72 rack-scale system. The standard terrestrial NVL72 combines 72 Rubin GPUs and 36 Vera CPUs, although **** eX and NVIDIA have not disclosed the final configuration of the orbital version. **** e Exploration Technologies Corp. (NASDAQ:SPCX) plans to launch the satellite in the fourth quarter of 2027 and reach substantial scale by 2028. Musk's plan isn't new; during **** eX's first earnings conference as a public company in August, he stated that the company would build exclusively on NVIDIA hardware in the future, calling the Vera Rubin architecture the best available AI computer design.
Musk's central point is that **** e is, in the long run, the most cost-effective area to develop AI computing. He cites solar power availability in orbit as a crucial advantage, and estimates that within two to three years, **** e might become the lowest-cost place for AI computing in general, describing the orbital architecture as simpler, less expensive, denser, and lighter than a standard data-center rack. Not everyone believes the physics and economics will align on Musk's timeframe. Microsoft President Brad Smith has publicly questioned the broader concept, telling reporters that he would be surprised if companies actually transferred computation from land to low-Earth orbit.
For NVIDIA Corporation (NASDAQ:NVDA), the read-through is simple: **** e-based computing would represent a new, if early-stage and speculative, source of demand for its Vera Rubin platform, on top of the company's strong position in terrestrial AI infrastructure. According to some **** yst models, **** eX accounts for approximately 5% of NVIDIA's revenue.
SpaceX's reasoning is more convoluted. The plan is entirely dependent on the success of Starship, **** eX's next-generation rocket system, which still needs to demonstrate its capacity to handle launch frequency and reliability on the scale Musk describes. When Musk said during **** eX's August earnings call that the company would build its future AI infrastructure exclusively on NVIDIA, NVDA shares rose more than 4%, while **** eX's shares fell more than 10% before paring losses, reflecting investor concerns about execution risk and capital intensity, despite the fact that the NVIDIA relationship was well received.
#Companies
The comment strengthens **** eX's Starmind concept, which aims to establish AI data centers in orbit rather than on the ground. The first satellite, named Starmind AI1, will carry a **** e-optimized version of NVIDIA's Vera Rubin NVL72 rack-scale system. The standard terrestrial NVL72 combines 72 Rubin GPUs and 36 Vera CPUs, although **** eX and NVIDIA have not disclosed the final configuration of the orbital version. **** e Exploration Technologies Corp. (NASDAQ:SPCX) plans to launch the satellite in the fourth quarter of 2027 and reach substantial scale by 2028. Musk's plan isn't new; during **** eX's first earnings conference as a public company in August, he stated that the company would build exclusively on NVIDIA hardware in the future, calling the Vera Rubin architecture the best available AI computer design.
Musk's central point is that **** e is, in the long run, the most cost-effective area to develop AI computing. He cites solar power availability in orbit as a crucial advantage, and estimates that within two to three years, **** e might become the lowest-cost place for AI computing in general, describing the orbital architecture as simpler, less expensive, denser, and lighter than a standard data-center rack. Not everyone believes the physics and economics will align on Musk's timeframe. Microsoft President Brad Smith has publicly questioned the broader concept, telling reporters that he would be surprised if companies actually transferred computation from land to low-Earth orbit.
For NVIDIA Corporation (NASDAQ:NVDA), the read-through is simple: **** e-based computing would represent a new, if early-stage and speculative, source of demand for its Vera Rubin platform, on top of the company's strong position in terrestrial AI infrastructure. According to some **** yst models, **** eX accounts for approximately 5% of NVIDIA's revenue.
SpaceX's reasoning is more convoluted. The plan is entirely dependent on the success of Starship, **** eX's next-generation rocket system, which still needs to demonstrate its capacity to handle launch frequency and reliability on the scale Musk describes. When Musk said during **** eX's August earnings call that the company would build its future AI infrastructure exclusively on NVIDIA, NVDA shares rose more than 4%, while **** eX's shares fell more than 10% before paring losses, reflecting investor concerns about execution risk and capital intensity, despite the fact that the NVIDIA relationship was well received.
#Companies
1 month ago
On August 6, James Hardie Industries (NYSE:JHX) reported results for the quarter ended June 30 and beat its own numbers by enough to raise guidance just three months into the fiscal year. Net sales jumped 64% year over year to $1.475 billion, adjusted EBITDA climbed 79% to $422.1 million, and both figures came in ahead of what management had originally guided investors to expect. For a company that closed a transformative acquisition less than a year earlier, that kind of overshoot forces a reassessment of the growth story ahead.
The headline growth number is inflated by the AZEK Exteriors deal folded into the base, so the more telling figure is the 12% pro forma net sales growth, which also beat original guidance. Siding & Trim, the core fiber cement business, posted organic net sales growth of 20% as North American fiber cement volumes returned to growth for the first time in several quarters. CEO Aaron Erter tied that to share gains against vinyl and other competing materials, along with programs like ColorPlus and Expanded Statement drawing more of the higher-end repair and remodel market. Adjusted EBITDA margin in that segment expanded 140 basis points to 33.5%, powered by favorable pricing, cheaper raw materials, and continued savings from the company's Hardie Manufacturing Operating System even as freight costs rose.
Management also said cost synergies from the AZEK integration are running ahead of schedule and revenue synergies are on track, evidenced by newly expanded nationwide distribution partnerships with Boise Cascade and other regional distributors. In Deck, Rail & Accessories, sell-through accelerated every month of the quarter and outpaced shipments, pulling channel inventory back to normal levels and setting up a cleaner back half of the year. Free cash flow more than doubled to $254.2 million, and the company used the cash to pay down $400 million of senior unsecured notes.
Erter was careful to frame the beat as execution rather than a healthier market, telling investors the company is "not ***** uming a housing market improvement" for the rest of fiscal 2027. Part of the quarter's strength came from an easy comparison, since channel inventory was deliberately reduced a year earlier, and management said that benefit is expected to moderate as the year goes on. Deck, Rail & Accessories net sales actually fell 5% on a pro forma basis because the company intentionally cut production to work down channel inventory, leaving the segment with an operating loss of $3.3 million for the quarter.
#Growth #sales #management
The headline growth number is inflated by the AZEK Exteriors deal folded into the base, so the more telling figure is the 12% pro forma net sales growth, which also beat original guidance. Siding & Trim, the core fiber cement business, posted organic net sales growth of 20% as North American fiber cement volumes returned to growth for the first time in several quarters. CEO Aaron Erter tied that to share gains against vinyl and other competing materials, along with programs like ColorPlus and Expanded Statement drawing more of the higher-end repair and remodel market. Adjusted EBITDA margin in that segment expanded 140 basis points to 33.5%, powered by favorable pricing, cheaper raw materials, and continued savings from the company's Hardie Manufacturing Operating System even as freight costs rose.
Management also said cost synergies from the AZEK integration are running ahead of schedule and revenue synergies are on track, evidenced by newly expanded nationwide distribution partnerships with Boise Cascade and other regional distributors. In Deck, Rail & Accessories, sell-through accelerated every month of the quarter and outpaced shipments, pulling channel inventory back to normal levels and setting up a cleaner back half of the year. Free cash flow more than doubled to $254.2 million, and the company used the cash to pay down $400 million of senior unsecured notes.
Erter was careful to frame the beat as execution rather than a healthier market, telling investors the company is "not ***** uming a housing market improvement" for the rest of fiscal 2027. Part of the quarter's strength came from an easy comparison, since channel inventory was deliberately reduced a year earlier, and management said that benefit is expected to moderate as the year goes on. Deck, Rail & Accessories net sales actually fell 5% on a pro forma basis because the company intentionally cut production to work down channel inventory, leaving the segment with an operating loss of $3.3 million for the quarter.
#Growth #sales #management
1 month ago
On September 9, 2026, Reuters reported that GE Aerospace (NYSE:GE) agreed to buy castings maker Consolidated Precision Products for $11.75 billion. It is its largest acquisition since becoming a standalone company in 2024, to secure the supply of the precision metal turbine-blade components that have been a persistent bottleneck across the jet engine industry. CPP is the world's third-largest maker of these parts. CEO Larry Culp called the capacity "mission-critical" as the company works through a backlog stretching into the next decade.
GE Aerospace (NYSE:GE) can use the acquisition to convert its massive backlog into revenue faster. The company's backlog exceeded $210 billion after its second-quarter results. It includes roughly $170 billion in commercial services and more than $30 billion in defense. The $11.75 billion acquisition of Consolidated Precision Products directly targets one of the supply-chain bottlenecks that has limited GE's ability to increase engine production. CPP supplies about one-quarter of GE's casting needs. It gives GE greater control over a critical manufacturing process and could help it meet deliveries tied to its long-term backlog.
Bringing CPP in-house could improve GE's production economics while reducing supplier dependence. Spare-parts delinquencies jumped 20% sequentially in the second quarter. It shows the ongoing operational impact of supply constraints. GE plans to apply its Flight Deck lean operating model at CPP to improve factory yields and machine utilization and reduce scrap and rework. The company expects the acquisition to generate about $200 million in net synergies and achieve double-digit return on invested capital by the fifth year. It gives investors a measurable path to stronger returns from the deal.
The acquisition makes GE's position solid in the next generation of engines. GE expects demand for airfoils to increase more than 30% by 2030 from 2026 levels. CPP's casting expertise could help GE bring new airfoil designs into production faster. The business also expects CPP to make roughly $2 billion in revenue in 2027. That combination gives investors a potential path to higher production capacity, faster technology development, and stronger long-term participation in commercial and defense aerospace demand.
GE Aerospace (NYSE:GE) must justify a nearly $12 billion investment, and investors already ******* ign a premium valuation to the stock. GE Aerospace trades at roughly 46 times forward earnings. It leaves investors with limited tolerance for execution problems or weaker-than-expected returns. The company will fund $7 billion of the acquisition with cash and finance the remainder with new debt. So GE needs CPP's earnings and operating improvements to make sufficient returns to support the purchase price and protect shareholder value.
#billion #backlog #supply
GE Aerospace (NYSE:GE) can use the acquisition to convert its massive backlog into revenue faster. The company's backlog exceeded $210 billion after its second-quarter results. It includes roughly $170 billion in commercial services and more than $30 billion in defense. The $11.75 billion acquisition of Consolidated Precision Products directly targets one of the supply-chain bottlenecks that has limited GE's ability to increase engine production. CPP supplies about one-quarter of GE's casting needs. It gives GE greater control over a critical manufacturing process and could help it meet deliveries tied to its long-term backlog.
Bringing CPP in-house could improve GE's production economics while reducing supplier dependence. Spare-parts delinquencies jumped 20% sequentially in the second quarter. It shows the ongoing operational impact of supply constraints. GE plans to apply its Flight Deck lean operating model at CPP to improve factory yields and machine utilization and reduce scrap and rework. The company expects the acquisition to generate about $200 million in net synergies and achieve double-digit return on invested capital by the fifth year. It gives investors a measurable path to stronger returns from the deal.
The acquisition makes GE's position solid in the next generation of engines. GE expects demand for airfoils to increase more than 30% by 2030 from 2026 levels. CPP's casting expertise could help GE bring new airfoil designs into production faster. The business also expects CPP to make roughly $2 billion in revenue in 2027. That combination gives investors a potential path to higher production capacity, faster technology development, and stronger long-term participation in commercial and defense aerospace demand.
GE Aerospace (NYSE:GE) must justify a nearly $12 billion investment, and investors already ******* ign a premium valuation to the stock. GE Aerospace trades at roughly 46 times forward earnings. It leaves investors with limited tolerance for execution problems or weaker-than-expected returns. The company will fund $7 billion of the acquisition with cash and finance the remainder with new debt. So GE needs CPP's earnings and operating improvements to make sufficient returns to support the purchase price and protect shareholder value.
#billion #backlog #supply
1 month ago
Digital Realty Trust, Inc. (NYSE:DLR) announced a joint venture with Rönesans Infrastructure on September 14 to develop and operate data centers in Türkiye. The first Ankara campus is designed for more than 22 megawatts of IT capacity. Land, power and permits are secured, early construction has begun, and the first facility is scheduled for completion in 2028.
Digital Realty Trust, Inc. (NYSE:DLR) has established credible development foundations. The investment question is whether those foundations can support attractive returns once construction spending, customer contracts, and operating costs enter the calculation.
For Digital Realty Trust, Inc. (NYSE:DLR), securing land, electricity and permits reduces uncertainty around whether development can proceed. That matters because customer interest has limited commercial value when a developer cannot offer a credible delivery schedule. Construction progress can make discussions with prospective tenants more concrete.
Digital Realty Trust, Inc. (NYSE:DLR) also combines its global customer relationships and operating experience with Rönesans Infrastructure's local development and construction capabilities. The potential benefit is practical: a partner familiar with local execution can help deliver the buildings, while an established data-center operator can help attract customers and manage their deployments.
Digital Realty Trust, Inc. (NYSE:DLR) is entering through a venture that also plans an additional Istanbul facility. A presence in both cities could appeal to customers seeking multiple locations for resilience and connectivity. Success in Ankara could therefore create a commercial foundation for further expansion, provided demand supports additional investment.
#digital #construction #development #venture
Digital Realty Trust, Inc. (NYSE:DLR) has established credible development foundations. The investment question is whether those foundations can support attractive returns once construction spending, customer contracts, and operating costs enter the calculation.
For Digital Realty Trust, Inc. (NYSE:DLR), securing land, electricity and permits reduces uncertainty around whether development can proceed. That matters because customer interest has limited commercial value when a developer cannot offer a credible delivery schedule. Construction progress can make discussions with prospective tenants more concrete.
Digital Realty Trust, Inc. (NYSE:DLR) also combines its global customer relationships and operating experience with Rönesans Infrastructure's local development and construction capabilities. The potential benefit is practical: a partner familiar with local execution can help deliver the buildings, while an established data-center operator can help attract customers and manage their deployments.
Digital Realty Trust, Inc. (NYSE:DLR) is entering through a venture that also plans an additional Istanbul facility. A presence in both cities could appeal to customers seeking multiple locations for resilience and connectivity. Success in Ankara could therefore create a commercial foundation for further expansion, provided demand supports additional investment.
#digital #construction #development #venture
1 month ago
On September 11, a caller praised The Boeing Company's (NYSE:BA) CEO and asked when the company would overcome the ongoing labor uncertainty and finally move beyond years of sideways stock performance. Mad Money host Jim Cramer replied:
I think that Boeing is ready to go up. But here's the problem. Every time crude goes up a dollar, the stock goes down a dollar. And that, think about it, that was actually the ratio. I did some work on this. And because today crude was down, Boeing went up $5... No, it's so stupid because, in truth, the airlines need more planes because the planes are more fuel-efficient. So they actually do better in this environment, but ******* ody cares. They know that airlines have to borrow money to buy planes and rates are higher, and they think that oil somehow's bad. But what ends up happening is the stock does nothing. I think it's about to go up because I think oil might be peaking unless there's some catastrophe over there.
The Boeing Company's (NYSE:BA) second-quarter results showed improving cash generation, but profitability remained weak. Revenue rose 8% year over year to $24.6 billion, while operating cash flow reached $1.4 billion and free cash flow was $631 million. Its total backlog reached a record $715 billion, including more than 6,200 commercial airplanes. CEO Kelly Ortberg said, "We're ramping up production just as we planned. That's driving higher revenues and improved cash flow." He also said there's more work ahead to ramp production, complete commercial-aircraft certifications and uphold customer commitments. Boeing said the 737-7 and 737-10 had completed flight testing, with deliveries expected to begin in 2027.
The Boeing Company's (NYSE:BA) large backlog has yet to translate into consistent commercial-aircraft profitability, leaving execution and margins as important concerns for investors. Commercial Airplanes delivered 171 aircraft in the second quarter but still posted a $322 million operating loss and a negative 2.7% operating margin. It also reported a $428 million GAAP net loss.
The balance sheet leaves less room for further setbacks. The company ended June with $45.9 billion of consolidated debt against $20 billion of cash and investments in marketable securities. The FAA certified the 737-7 on August 3, while Boeing continues working toward certification of the 737-10. First deliveries of the variants are expected in 2027. The company also recorded $280 million of losses on the VC-25B program in the quarter.
#boeing #cash #commercial
I think that Boeing is ready to go up. But here's the problem. Every time crude goes up a dollar, the stock goes down a dollar. And that, think about it, that was actually the ratio. I did some work on this. And because today crude was down, Boeing went up $5... No, it's so stupid because, in truth, the airlines need more planes because the planes are more fuel-efficient. So they actually do better in this environment, but ******* ody cares. They know that airlines have to borrow money to buy planes and rates are higher, and they think that oil somehow's bad. But what ends up happening is the stock does nothing. I think it's about to go up because I think oil might be peaking unless there's some catastrophe over there.
The Boeing Company's (NYSE:BA) second-quarter results showed improving cash generation, but profitability remained weak. Revenue rose 8% year over year to $24.6 billion, while operating cash flow reached $1.4 billion and free cash flow was $631 million. Its total backlog reached a record $715 billion, including more than 6,200 commercial airplanes. CEO Kelly Ortberg said, "We're ramping up production just as we planned. That's driving higher revenues and improved cash flow." He also said there's more work ahead to ramp production, complete commercial-aircraft certifications and uphold customer commitments. Boeing said the 737-7 and 737-10 had completed flight testing, with deliveries expected to begin in 2027.
The Boeing Company's (NYSE:BA) large backlog has yet to translate into consistent commercial-aircraft profitability, leaving execution and margins as important concerns for investors. Commercial Airplanes delivered 171 aircraft in the second quarter but still posted a $322 million operating loss and a negative 2.7% operating margin. It also reported a $428 million GAAP net loss.
The balance sheet leaves less room for further setbacks. The company ended June with $45.9 billion of consolidated debt against $20 billion of cash and investments in marketable securities. The FAA certified the 737-7 on August 3, while Boeing continues working toward certification of the 737-10. First deliveries of the variants are expected in 2027. The company also recorded $280 million of losses on the VC-25B program in the quarter.
#boeing #cash #commercial
1 month ago
On the September 11 episode of Mad Money, Jim Cramer expressed strong optimism for Brinker International, Inc. (NYSE:EAT) ahead of its upcoming **** yst presentation, as he said:
Thursday, we have two important **** yst meetings. Brinker... We have them all the time on the show. Brinker, you know, is Chili's, and the company never fails to wow me. I think this meeting will be no exception.
Brinker International, Inc. (NYSE:EAT) continues to demonstrate operational strength across the casual dining sector, driven by sustained customer traffic and menu innovation at Chili's Grill & Bar. In its fourth quarter of fiscal 2026, the company generated $1.54 billion in total revenue, bringing full-year revenues to $5.81 billion. Adjusted earnings per share for the quarter reached $3.07, representing a 23% year-over-year increase.
Chili's reported a 5.6% increase in comparable store sales, marking its 21st consecutive quarter of positive same-store sales growth. The sustained momentum has been supported by the ongoing success of the $10.99 "3 for Me" everyday value platform as well as targeted menu launches, including the Big Crispy Chicken Sandwich, which helped support traffic as Chili's continued positioning its value proposition against fast-food offerings. According to the company's CEO Kevin Hochman, the Big Crispy Chicken Sandwich "overdelivered" on the management's estimates.
Despite consistent top-line momentum, Brinker International, Inc. (NYSE:EAT) faces ongoing execution risks **** ociated with sticky cost inflation and broader macroeconomic pressures on consumer spending. Elevated wholesale prices for core commodities, especially beef and produce, continue to weigh on restaurant operating costs, while wage growth across regional markets keeps labor expenses elevated.
#elevated #analyst
Thursday, we have two important **** yst meetings. Brinker... We have them all the time on the show. Brinker, you know, is Chili's, and the company never fails to wow me. I think this meeting will be no exception.
Brinker International, Inc. (NYSE:EAT) continues to demonstrate operational strength across the casual dining sector, driven by sustained customer traffic and menu innovation at Chili's Grill & Bar. In its fourth quarter of fiscal 2026, the company generated $1.54 billion in total revenue, bringing full-year revenues to $5.81 billion. Adjusted earnings per share for the quarter reached $3.07, representing a 23% year-over-year increase.
Chili's reported a 5.6% increase in comparable store sales, marking its 21st consecutive quarter of positive same-store sales growth. The sustained momentum has been supported by the ongoing success of the $10.99 "3 for Me" everyday value platform as well as targeted menu launches, including the Big Crispy Chicken Sandwich, which helped support traffic as Chili's continued positioning its value proposition against fast-food offerings. According to the company's CEO Kevin Hochman, the Big Crispy Chicken Sandwich "overdelivered" on the management's estimates.
Despite consistent top-line momentum, Brinker International, Inc. (NYSE:EAT) faces ongoing execution risks **** ociated with sticky cost inflation and broader macroeconomic pressures on consumer spending. Elevated wholesale prices for core commodities, especially beef and produce, continue to weigh on restaurant operating costs, while wage growth across regional markets keeps labor expenses elevated.
#elevated #analyst
1 month ago
Rocket Lab (RKLB) stock has traded between $39.48 and $150.23 over the past 52 weeks. It now sits about 58% below its 52-week high, and anyone who bought twelve months ago is still up about 19%. None of that tells you what you would be buying today. Rocket Lab sells two quite different things, and the one its name points at is the smaller of them.
In Q2 2026 the ****** e Systems segment brought in $189.5 million. Launch Services brought in $44.6 million, down 30% from the previous quarter despite a similar number of launches. Management attributes that drop to accounting rather than lost work, because revenue from those launches is recognized over time and much of it had already been booked.
So Rocket Lab earns most of its revenue building satellites and their parts. Electron flew its 16th mission of 2026 in September. Launch is a real franchise, and it is not where most of the money comes from.
The stock trades at 52 times sales, against 3.1 for the S&P 500, on revenue of about $0.8 billion over the trailing twelve months. At this valuation, investors are largely pricing in future execution on the Neutron medium-lift rocket and the financial impact of the pending Iridium acquisition, rather than current satellite production alone. Management targets delivery to the pad in Q4 2026, and says the window for a launch before the end of 2026 is narrowing.
And you are paying for Iridium, which Rocket Lab has agreed to buy and expects to close in mid-2027. Iridium, a global satellite communications network, serves more than 2.5 million subscribers and delivered over $870 million of revenue in its past year. That is more than Rocket Lab's whole trailing twelve months. Management calls it a relatively slow-growing business that brings profit rather than a hole in the income statement.
#million #management #revenue
In Q2 2026 the ****** e Systems segment brought in $189.5 million. Launch Services brought in $44.6 million, down 30% from the previous quarter despite a similar number of launches. Management attributes that drop to accounting rather than lost work, because revenue from those launches is recognized over time and much of it had already been booked.
So Rocket Lab earns most of its revenue building satellites and their parts. Electron flew its 16th mission of 2026 in September. Launch is a real franchise, and it is not where most of the money comes from.
The stock trades at 52 times sales, against 3.1 for the S&P 500, on revenue of about $0.8 billion over the trailing twelve months. At this valuation, investors are largely pricing in future execution on the Neutron medium-lift rocket and the financial impact of the pending Iridium acquisition, rather than current satellite production alone. Management targets delivery to the pad in Q4 2026, and says the window for a launch before the end of 2026 is narrowing.
And you are paying for Iridium, which Rocket Lab has agreed to buy and expects to close in mid-2027. Iridium, a global satellite communications network, serves more than 2.5 million subscribers and delivered over $870 million of revenue in its past year. That is more than Rocket Lab's whole trailing twelve months. Management calls it a relatively slow-growing business that brings profit rather than a hole in the income statement.
#million #management #revenue
1 month ago
Answering a caller's query about The Procter & Gamble Company (NYSE:PG) during the lightning round of the September 10 episode of Mad Money, Jim Cramer said:
It's a tough stock. It's a tough stock because they don't have the growth that I want. They do have the 3% yield, but that's not enough. So, I'm going to say, you know, we sold it for the club. Don't look back.
The Procter & Gamble Company's (NYSE:PG) upside relies on elite operational execution and pricing power in high-margin categories. Continuous supply chain savings and an aggressive premiumization push toward items like Tide PODS help protect profitability. Combined with strong free cash flow productivity, management returned roughly $15 billion in FY 2026 through dividends and share buybacks, ensuring a steady earnings floor despite slow top-line growth.
The primary headwind is weak top-line momentum, with organic sales flat in the second quarter as challenging consumer trends, particularly in the U.S., weighed on growth. Foreign exchange friction and cost pressures further cap near-term earnings acceleration. Additionally, while the stock offers a reliable 3% dividend yield, that income profile creates a steep opportunity cost when risk-free ******* ets and higher-growth stocks offer attractive returns. We recently discussed what Cramer thinks is the ideal valuation for a good entry point in our article, "Jim Cramer Discusses Procter & Gamble (PG) Valuation and Growth."
According to Insider Monkey's data, 83 hedge funds had a stake in The Procter & Gamble Company (NYSE:PG) in Q2 compared to 78 in the prior quarter. Short percentage of the float is 1.21%, showing its status as a defensive holding rather than a short target. While the company provides exceptional balance sheet stability and reliable cash returns for defensive portfolios, its modest top-line growth trajectory and premium valuation continue to test investor patience, validating Cramer's decision to reallocate capital toward faster-moving opportunities.
#company
It's a tough stock. It's a tough stock because they don't have the growth that I want. They do have the 3% yield, but that's not enough. So, I'm going to say, you know, we sold it for the club. Don't look back.
The Procter & Gamble Company's (NYSE:PG) upside relies on elite operational execution and pricing power in high-margin categories. Continuous supply chain savings and an aggressive premiumization push toward items like Tide PODS help protect profitability. Combined with strong free cash flow productivity, management returned roughly $15 billion in FY 2026 through dividends and share buybacks, ensuring a steady earnings floor despite slow top-line growth.
The primary headwind is weak top-line momentum, with organic sales flat in the second quarter as challenging consumer trends, particularly in the U.S., weighed on growth. Foreign exchange friction and cost pressures further cap near-term earnings acceleration. Additionally, while the stock offers a reliable 3% dividend yield, that income profile creates a steep opportunity cost when risk-free ******* ets and higher-growth stocks offer attractive returns. We recently discussed what Cramer thinks is the ideal valuation for a good entry point in our article, "Jim Cramer Discusses Procter & Gamble (PG) Valuation and Growth."
According to Insider Monkey's data, 83 hedge funds had a stake in The Procter & Gamble Company (NYSE:PG) in Q2 compared to 78 in the prior quarter. Short percentage of the float is 1.21%, showing its status as a defensive holding rather than a short target. While the company provides exceptional balance sheet stability and reliable cash returns for defensive portfolios, its modest top-line growth trajectory and premium valuation continue to test investor patience, validating Cramer's decision to reallocate capital toward faster-moving opportunities.
#company
1 month ago
Wolfe Research upgraded two prominent pharmaceutical companies to Outperform on August 13. The firm upgraded both Biogen Inc. (NASDAQ:BIIB) and AbbVie Inc. (NYSE:ABBV)'s ratings from Peer Perform, with Wolfe ***** igning them similar $300 price targets. The firm's logic in each case was based on a comparable set of factors: pipelines that the market appears to undervalue, and valuations that Wolfe believes are too low given each company's growth track.
Wolfe's thesis for Biogen Inc. (NASDAQ:BIIB) is mainly based on late-stage clinical programs, which it believes the stock has yet to reflect. The firm focused on two experimental therapies in particular, both of which have key late-stage clinical readouts expected over the coming year: litifilimab, which Wolfe believes could be the first biologic approved for cutaneous lupus erythematosus, and felzartamab, which the firm claims represents a bigger commercial opportunity in antibody-mediated transplant rejection than Wall Street currently thinks.
Wolfe also cited Biogen's acquisition of Apellis Pharmaceuticals as strengthening its near-term revenue base through the FDA-approved drugs Empaveli and Syfovre. That move is part of an overall pattern of Biogen Inc. (NASDAQ:BIIB) diversifying beyond its core neurology brand, with the company completing its acquisition of RayThera on August 6, adding another early-stage immunology platform to its pipeline.
Wolfe's Biogen Inc. (NASDAQ:BIIB) thesis is incomplete without valuation. The firm believes the stock is trading at a discount to the broader market, despite the company's development on Leqembi, its Alzheimer's medication, and what Wolfe described as solid commercial execution overall.
AbbVie's upgrade is based on a slightly different premise: patent strength and cash generation rather than simple clinical events. Wolfe stated that AbbVie's 2027 earnings multiple of 14.6x seemed too low for a company that forecasts high-single-digit revenue growth for the rest of the decade. AbbVie's patent position, according to Wolfe, sets the company apart from its competitors in a way that the market has yet to completely price in.
#wolfe #firm #market #clinical
Wolfe's thesis for Biogen Inc. (NASDAQ:BIIB) is mainly based on late-stage clinical programs, which it believes the stock has yet to reflect. The firm focused on two experimental therapies in particular, both of which have key late-stage clinical readouts expected over the coming year: litifilimab, which Wolfe believes could be the first biologic approved for cutaneous lupus erythematosus, and felzartamab, which the firm claims represents a bigger commercial opportunity in antibody-mediated transplant rejection than Wall Street currently thinks.
Wolfe also cited Biogen's acquisition of Apellis Pharmaceuticals as strengthening its near-term revenue base through the FDA-approved drugs Empaveli and Syfovre. That move is part of an overall pattern of Biogen Inc. (NASDAQ:BIIB) diversifying beyond its core neurology brand, with the company completing its acquisition of RayThera on August 6, adding another early-stage immunology platform to its pipeline.
Wolfe's Biogen Inc. (NASDAQ:BIIB) thesis is incomplete without valuation. The firm believes the stock is trading at a discount to the broader market, despite the company's development on Leqembi, its Alzheimer's medication, and what Wolfe described as solid commercial execution overall.
AbbVie's upgrade is based on a slightly different premise: patent strength and cash generation rather than simple clinical events. Wolfe stated that AbbVie's 2027 earnings multiple of 14.6x seemed too low for a company that forecasts high-single-digit revenue growth for the rest of the decade. AbbVie's patent position, according to Wolfe, sets the company apart from its competitors in a way that the market has yet to completely price in.
#wolfe #firm #market #clinical
1 month ago
Interested in 3M Company? Here are five stocks we like better.
3M says it is ahead of its 2027 targets, citing 5.4% second-quarter organic growth, higher margins, improved execution and on-time, in-full delivery rising to about 90%.
Data centers are a major growth priority. Its expanded beam optics technology has been standardized by Microsoft Azure, is being evaluated by five other hyperscalers, and could address a market approaching $2 billion within the next two years.
Innovation and cost reductions are supporting the outlook: 3M plans more than 350 new-product launches this year, is consolidating factories, expects to offset $150 million–$175 million in oil-related costs through pricing, and is tracking above its 25% operating-margin goal for next year.
3 Stocks Whose Charts May Be Signaling the Next Big Move
#company
3M says it is ahead of its 2027 targets, citing 5.4% second-quarter organic growth, higher margins, improved execution and on-time, in-full delivery rising to about 90%.
Data centers are a major growth priority. Its expanded beam optics technology has been standardized by Microsoft Azure, is being evaluated by five other hyperscalers, and could address a market approaching $2 billion within the next two years.
Innovation and cost reductions are supporting the outlook: 3M plans more than 350 new-product launches this year, is consolidating factories, expects to offset $150 million–$175 million in oil-related costs through pricing, and is tracking above its 25% operating-margin goal for next year.
3 Stocks Whose Charts May Be Signaling the Next Big Move
#company
1 month ago
In XRP news today, its 30-day liquidity index on Binance has climbed to 0.0675, the highest reading in about six months. Its 30-day turnover recovered to approximately $4.6 billion after sinking to between $2 billion and $3 billion during July and August.
The rebound signals that XRP liquidity conditions have meaningfully improved, but a deeper order book supports both accumulation and distribution equally well, and is leaving the question of which side actually controls this market unanswered.
The liquidity index measures how easily traders can move XRP in and out of positions without moving the price against themselves, calculated against how quickly XRP turns over relative to what Binance holds on its books. A rising reading means faster turnover and tighter execution, which is exactly what the data shows.
XRP closed August up about 28.5%, its strongest August performance since 2021, while U.S. spot XRP ETF products pulled in $153.55 million of inflows that month.
Now, the flow data from the end of last week complicates a clean bullish read. More than 91 million XRP moved into Binance on the 11th, and over 113 million XRP moved out, both six-month highs in single-day volume. Withdrawals outpaced deposits by 22.7 million XRP, yet Binance's total XRP holdings rose just 0.43% over the full week.
#reading
The rebound signals that XRP liquidity conditions have meaningfully improved, but a deeper order book supports both accumulation and distribution equally well, and is leaving the question of which side actually controls this market unanswered.
The liquidity index measures how easily traders can move XRP in and out of positions without moving the price against themselves, calculated against how quickly XRP turns over relative to what Binance holds on its books. A rising reading means faster turnover and tighter execution, which is exactly what the data shows.
XRP closed August up about 28.5%, its strongest August performance since 2021, while U.S. spot XRP ETF products pulled in $153.55 million of inflows that month.
Now, the flow data from the end of last week complicates a clean bullish read. More than 91 million XRP moved into Binance on the 11th, and over 113 million XRP moved out, both six-month highs in single-day volume. Withdrawals outpaced deposits by 22.7 million XRP, yet Binance's total XRP holdings rose just 0.43% over the full week.
#reading
